Neliva

MRKMerck & Co. Inc.

HealthcareUpdated 2026-03-11
$116.21-0.75%
Open
$116.76
High
$116.95
Low
$115.28
Volume
6.7M
Market Cap
$288.44B
P/E Ratio
15.80
P/B Ratio
5.48
Enterprise Value
$323.21B

Get AI-Powered Analysis of MRK

Neliva uses real-time data and AI to provide deep research on Merck & Co. Inc. — including fundamentals, risk assessment, earnings review, and actionable insights.

Research MRK with AIDeep Analysis

Free to try — no account required for your first research.

About Merck & Co. Inc. (MRK)

Merck & Co. Inc. (MRK) is a publicly traded company in the Healthcare sector, listed as a component of the S&P 500 index. With a market capitalization of $288.44B, it is one of the significant players in its industry. The stock currently trades at a price-to-earnings ratio of 15.80.

Investors and analysts track MRK for its performance within the Healthcare sector. Using Neliva's AI-powered research tools, you can get comprehensive analysis including real-time pricing, fundamental analysis, technical indicators, news sentiment, and risk assessment — all in seconds.

Frequently Asked Questions

What is the current price of MRK?
As of 2026-03-11, MRK is trading at $116.21 (-0.75% today). Range: $115.28 — $116.95.
What is the P/E ratio of MRK?
MRK has a P/E ratio of 15.80, helping assess valuation relative to earnings.
Is MRK a good stock to buy?
Whether MRK is a good investment depends on your goals and risk tolerance. Neliva’s AI provides comprehensive analysis including valuation, growth, risk factors, and analyst consensus.
What sector is MRK in?
Merck & Co. Inc. (MRK) is in the Healthcare sector of the S&P 500.

Related Healthcare Stocks

LLYEli Lilly and CompanyUNHUnitedHealth Group Inc.JNJJohnson & JohnsonABBVAbbVie Inc.TMOThermo Fisher Scientific Inc.ABTAbbott LaboratoriesISRGIntuitive Surgical Inc.PFEPfizer Inc.

Research any stock with AI

Get real-time data, fundamental analysis, risk assessment, and actionable insights — powered by AI.

Get started free